On Dec. 18, Victor Willoughby lost his life to Ebola, just hours following the arrival of ZMab, an experimental drug that had been flown to Sierra Leone from Brussels to treat the physician after he had contracted the disease from a patient.Sadly, Willoughby's death is more the rule than an exception.